In sum, mutant IDH causes metabolic reprogramming with production of D-2-HG that results in dysregulation of gene expression, differentiation status, DNA damage repair, inflammation, intracellular trafficking, ageing and cell death programs in cancer cells (8). The gene discussed is IDH2; the disease is cancer.